Jan Stange

Title: Jan Stange: Innovator in Albumin Binding Methods

Introduction

Jan Stange is a notable inventor based in Rostock, Germany. He has made significant contributions to the field of biochemistry, particularly in methods related to albumin binding. With a total of 7 patents to his name, Stange's work has the potential to impact various medical and research applications.

Latest Patents

Stange's latest patents include innovative methods for determining the amount of functional albumin. One method involves providing a test sample containing a defined amount of albumin of unknown binding capacity and a reference sample with a known binding capacity. The process includes incubating these samples with an albumin-binding marker, detecting unbound markers, and ultimately determining the amount of functional albumin based on the detected presence of the marker. Another patent focuses on determining the relative binding capacity of albumin, utilizing measurement solutions that exceed the presumed available binding capacity. This method also involves the detection of unbound markers to ascertain the relative binding capacity of albumin in test samples.

Career Highlights

Throughout his career, Jan Stange has worked with various organizations, including the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. His expertise in biochemistry and innovative approaches to albumin binding have positioned him as a key figure in his field.

Collaborations

Stange has collaborated with notable colleagues such as Steffen Mitzner and Sebastian Klammt. Their combined efforts have contributed to advancements in the understanding and application of albumin-binding methods.

Conclusion

Jan Stange's contributions to the field of biochemistry, particularly in albumin binding methods, showcase his innovative spirit and dedication to research. His patents reflect a commitment to advancing scientific knowledge and improving practical applications in medicine and research.